JCIC Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$53.1K Hold
875
0.02% 80
2026
Q1
$53.1K Buy
875
+535
+157% +$31.2K 0.02% 80
2025
Q4
$18.3K Hold
340
0.01% 97
2025
Q3
$15.3K Buy
+340
New +$15.9K ﹤0.01% 99
2025
Q1
$31.7K Buy
520
+180
+53% +$10.5K 0.01% 81
2024
Q4
$19.2K Hold
340
0.01% 83
2024
Q3
$17.6K Hold
340
0.01% 84
2024
Q2
$14.1K Hold
340
0.01% 90
2024
Q1
$18.4K Hold
340
0.01% 89
2023
Q4
$17.4K Sell
340
-600
-64% -$31.5K 0.01% 91
2023
Q3
$54.6K Hold
940
0.03% 64
2023
Q2
$60.1K Hold
940
0.03% 66
2023
Q1
$65.2K Hold
940
0.03% 59
2022
Q4
$68K Hold
940
0.03% 61
2022
Q3
$73K Sell
940
-789
-46% -$57.2K 0.03% 60
2022
Q2
$133K Hold
1,729
0.07% 49
2022
Q1
$126K Buy
1,729
+600
+53% +$40.3K 0.04% 64
2021
Q4
$70K Sell
1,129
-730
-39% -$42.8K 0.02% 74
2021
Q3
$110K Hold
1,859
0.04% 65
2021
Q2
$154K Hold
1,859
0.04% 67
2021
Q1
$117K Buy
1,859
+340
+22% +$21.2K 0.04% 64
2020
Q4
$94K Buy
1,519
+789
+108% +$48.5K 0.04% 63
2020
Q3
$44K Buy
730
+110
+18% +$6.62K 0.02% 68
2020
Q2
$36K Buy
620
+170
+38% +$10.2K 0.02% 67
2020
Q1
$25K Buy
+450
New +$27.5K 0.02% 68

Other funds holding BMY

JCIC Asset Management's BMY Position: Q2 2026 in Review

JCIC Asset Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 875 shares worth $53.1K. The position accounts for 0.02% of the portfolio, ranked #80.

JCIC Asset Management first reported a position in BMY in Q1 2020 and has held it in 25 quarters since. The position peaked at $154K in Q2 2021. 566 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • JCIC Asset Management held 875 shares of Bristol-Myers Squibb worth $53.1K as of Q2 2026.
  • JCIC Asset Management left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.02% of JCIC Asset Management's portfolio in Q2 2026, its #80 holding.
  • JCIC Asset Management first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 25 quarters since.
  • JCIC Asset Management's Bristol-Myers Squibb position peaked at $154K in Q2 2021.
  • 566 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on JCIC Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.